Key result
Chronic intermittent hypobaric hypoxia protects against ischemia-reperfusion arrhythmia in a metabolic syndrome rat model.
Why the study?
The anti-arrhythmic effects and cellular mechanisms of chronic intermittent hypobaric hypoxia in metabolic syndrome remain to be elucidated.
Should not change clinical practice in metabolic syndrome; leaves open translation of hypoxia protection to human arrhythmia models.
This study investigated the anti-arrhythmic effects from chronic intermittent hypobaric hypoxia (CIHH) and the cellular mechanisms in rats with metabolic syndrome. Male Sprague-Dawley rats were randomly distributed among the control, fructose-fed (fed with 10% fructose in the drinking water to induce metabolic syndrome), CIHH (42 days of hypobaric hypoxia treatment simulating an altitude of 5000 m a.s.l.: PB = 404 mm Hg, PO2 = 84 mm Hg, 6 h per day), and the CIHH plus fructose (CIHH-F) groups. In anesthetized rats, the arrhythmia score was determined after 30 min of cardiac ischemia followed by 120 min of reperfusion. Action potentials (AP) were recorded from isolated ventricular papillary muscles. The arrhythmia score was much lower in CIHH-F rats than in the fructose-fed rats. Under basic conditions, AP duration (APD) was significantly shortened in fructose-fed rats, but obviously prolonged in CIHH rats compared with that of the control rats. During ischemia, the AP amplitude, the maximal rate of rise of phase 0, APD, and resting potential, were lower in the control, fructose-fed, and CIHH-F groups, but were not changed in the CIHH rats. The lower AP during ischemia did not recover after washout for the fructose-fed rats. In conclusion, CIHH protects the heart against ischemia-reperfusion induced arrhythmia in rats with metabolic syndrome. This effect of CIHH is possibly related to baseline prolongation of the AP and attenuation of AP reduction during ischemia-reperfusion.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2014) studied Metabolic syndrome and cardiac ischemia-reperfusion arrhythmia. Chronic intermittent hypobaric hypoxia (CIHH) vs. Fructose-fed rats without CIHH treatment was evaluated on Arrhythmia score after 30 min of cardiac ischemia followed by 120 min of reperfusion. Chronic intermittent hypobaric hypoxia protects the heart against ischemia-reperfusion induced arrhythmia in male rats with fructose-induced metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: